AIM
ONC

AXA Investment Managers’s BeOne Medicines Ltd ONC Stock Holding History

AXA Investment Managers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.3M Buy
+36,011
New +$10.9M 0.03% 370

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXA Investment Managers's ONC Position: Q3 2025 in Review

AXA Investment Managers opened a new position in BeOne Medicines Ltd (ONC) in Q3 2025: 36,011 shares worth $12.3M. The stake represents 0.03% of the portfolio and ranks #370 among its holdings.

265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • AXA Investment Managers held 36,011 shares of BeOne Medicines Ltd worth $12.3M as of Q3 2025.
  • BeOne Medicines Ltd was a new AXA Investment Managers position in Q3 2025.
  • BeOne Medicines Ltd made up 0.03% of AXA Investment Managers's portfolio in Q3 2025, its #370 holding.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.